Previous 10 | Next 10 |
Kala Pharmaceuticals press release ( NASDAQ: KALA ): Q4 GAAP EPS of -$7.97 misses by $1.42 . As of December 31, 2022, Kala had cash and cash equivalents of $70.5 million, compared to $52.4 million as of September 30, 2022. Based on its current plans, Kala anticipates that ...
-- Enrolled first patient in CHASE Phase 2b clinical trial evaluating KPI-012 for PCED; Top-line data targeted for 1Q 2024 -- -- Closed $31.0 million private placement financing, extending cash runway into 1Q 2025 -- ARLINGTON, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- Kala Pharma...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips While everyone knows that in order to have a market, there must be bulls and bears, that’s not going to stop people from attempting to garner intense profits from top short-squeeze candidates. To quickly summarize, sho...
Summary FDA Accepted IND Filing for the company to initiate a phase 2b study using KPI-012 for the treatment of patients with the persistent corneal epithelial defect. The phase 2b study, using KPI-012 for the treatment of patients with a persistent corneal epithelial defect, is expecte...
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports and conference presentations. ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips While a lot of signs point to the macro environment remaining difficult throughout 2023, now’s not the time to sit on the sidelines. In fact, as fear, uncertainty, and doubt continue to rock the markets, it remains a goo...
Stocks To Watch: Citigroup, Wells Fargo And JPMorgan Lead off Earnings Season Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, inclu...
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports and conference presentations. ...
Saying 2022 was a “wild” year in the stock market is quite an understatement, in my opinion. Not only did we see a crash, but plenty of well-known companies became penny stocks . Yes, that’s correct; by definition, notable names slipped below the $5 threshold. While that ...
Palm Beach, FL – December 30, 2022 – FinancialNewsMedia.com News Commentary – According to the Centers for Disease Control and Prevention, arthritis affects approximately one in every four Americans, or 58.5 million people. The global rheumatoid arthritis drugs market is ...
News, Short Squeeze, Breakout and More Instantly...
Kala Pharmaceuticals Inc. Company Name:
KALA Stock Symbol:
NASDAQ Market:
Kala Pharmaceuticals Inc. Website:
2024-07-27 11:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 30.9% to $0.6 on volume of 558,931,853 shares NVIDIA Corporation (NVDA) fell 1.9% to $123.99 on volume of 249,243,816 shares Assure Holdings Corp. (IONM) rose 82.8% to $0.424 on vol...
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) is one of today's top gainers. The company's shares have moved 44.91% on the day to $6.55. Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus pe...